Rendering

Component: (Network and Table)
Network
053 - Disclosure - Note 12 - Equity Incentive Plan - Assumptions Used to Estimate Fair Value of Stock Options and Stock Appreciation Rights Awards (Details)
(http://www.anikatherapeutics.com/20161231/role/statement-note-12-equity-incentive-plan-assumptions-used-to-estimate-fair-value-of-stock-options-and-stock-appreciation-rights-awards-details)
TableStatement [Table]
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000898437 (http://www.sec.gov/CIK)
Scenario [Axis]Scenario, Unspecified [Domain]
Statement [Line Items]Period [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Range [Axis]Range [Axis]Range [Axis]
Minimum [Member]Maximum [Member]Range [Domain]Minimum [Member]Maximum [Member]Range [Domain]Minimum [Member]Maximum [Member]Range [Domain]
Risk free interest rate
0.94%  
1.55%  
 
1.15%  
1.46%  
 
1.16%  
1.39%  
 
Expected volatility
47.33%  
51.61%  
 
53.15%  
54.65%  
 
53.28%  
57.05%  
 
Expected life (years) (Year)
  
P4Y182D  
  
P4Y182D  
  
P4Y  
Expected dividend yield
  
0.00%  
  
0.00%  
  
0.00%